These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19504824)

  • 1. [Update: treatment of multiple sclerosis].
    Kümpfel T; Hohlfeld R
    MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Voltz R; Hohlfeld R
    Nervenarzt; 1992 Dec; 63(12):773-5. PubMed ID: 1494395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of multiple sclerosis.
    Blasier MG
    Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J; Lublin FD
    Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies].
    Pette M; Hartung HP; Toyka KV
    Nervenarzt; 1994 Apr; 65(4):271-4. PubMed ID: 8015636
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis.
    Karenfort M; Kieseier BC; Tibussek D; Assmann B; Schaper J; Mayatepek E
    Dev Med Child Neurol; 2009 Feb; 51(2):159-61. PubMed ID: 19191848
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM; Rainka MM; Patel MJ; Gengo FM
    Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].
    Sellebjerg FT; Sørensen PS;
    Ugeskr Laeger; 2007 Mar; 169(12):1121. PubMed ID: 17394832
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials in multiple sclerosis.
    Noseworthy JH
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):209-15. PubMed ID: 8481565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suspected multiple sclerosis].
    Pellkofer H; Hohlfeld R
    MMW Fortschr Med; 2006 Mar; 148(13):63-4. PubMed ID: 16642711
    [No Abstract]   [Full Text] [Related]  

  • 14. Balancing risk and reward: the question of natalizumab.
    Hauser SL; Johnston SC
    Ann Neurol; 2009 Sep; 66(3):A7-8. PubMed ID: 19810091
    [No Abstract]   [Full Text] [Related]  

  • 15. Knowns and unknowns in the future of multiple sclerosis treatment.
    Stüve O
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S30-6. PubMed ID: 20106346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in combination therapy for multiple sclerosis.
    Cohen JA
    Lancet Neurol; 2009 Jun; 8(6):502-3. PubMed ID: 19409855
    [No Abstract]   [Full Text] [Related]  

  • 17. [Copolymer 1 in therapy of multiple sclerosis].
    Weilbach FX; Voltz R; Hohlfeld R; Hartung HP
    Nervenarzt; 1995 Jun; 66(6):473-7. PubMed ID: 7543660
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab in relapsing-remitting multiple sclerosis.
    Schrijver HM
    N Engl J Med; 2008 Jun; 358(24):2645; author reply 2646-7. PubMed ID: 18557177
    [No Abstract]   [Full Text] [Related]  

  • 19. Is natalizumab overshooting its rebound?
    Fox RJ; Kappos L
    Neurology; 2008 Mar; 70(13 Pt 2):1073-4. PubMed ID: 18362270
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
    Carroll WM
    Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.